USANA HEALTH SCIENCES INC — Form 8-K
Filed August 4, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 62/100
What the filing says
USANA (NYSE: USNA) reported Q2 2026 net loss of $21.4M vs. prior-year earnings of $9.7M on consolidated net sales of $223M (down 5% YoY). Core driver: $29.1M non-cash goodwill impairment charge against Hiya Health (78.8%-owned subsidiary). Hiya revenue fell 17% YoY to $28M; active monthly subscribers declined to 166K from 200.4K. Rise Wellness sales fell 75% sequentially to $3M due to packaging disruption. FY2026 guidance slashed: consolidated net sales cut to $910M (from $925M–$1.0B range); net loss revised to $(11)M (from $20M–$27M earnings); Adjusted diluted EPS cut to $0.76 (from $1.95–$2.29). Company holds $169M cash, zero debt.
Why this rating
Material miss on ventures; $29M impairment equals 9% of market cap. Guidance slash ~12% on net sales; Hiya decline structural. Core business stable (−4% YoY). Relative to $328M market cap, major setback; mitigated by debt-free balance sheet and core resilience.
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.